Ann: IHL-42X positive phase 2 clinical trial results, page-380

First 380 Last

Share
Profile

Follow
Oldpa1

617 Posts.

103

17/04/22

07:33

Post #: 60884856
Share

Originally posted by MickeyMantle536: ↑

Good to hear your friend is getting relief. IMO these types of solutions won’t be required if the IHL trials continue to demonstrate efficacy.

IHL-42X is treating the underlying condition not just providing a mechanical intervention to improve the airway and/or ventilation. The mouth guard and CPAP are effective but crude and cumbersome. The only reason they’re tolerated is because there’s no other solution… yet.

There’s a legitimate pharmacotherapy interaction occurring based on what IHL have demonstrated so far. The full trial report with dosing has the potential to blow the absolute lid off this stock. It will be IP protected, the first and only pharmaceutical to treat OSA and a massive takeover target from big Pharma IMO.

Look at GSK moving into the cannabinol space. Long term shareholders understand the opportunity. Short term traders can look for cents in the dollar but they’ll miss all the upside we’re about to enjoy.

I no longer care what punters do because the “writing is on the wall” and IMO this stock could easily be multiple dollars.

Expand

In addition to the OSA trial at the Alfred Terry O'Brien 'was also looking at end points in relation to epilepsy. It will be very interesting to see how these stand within the context of the full report.

IHL Price at posting: 45.5¢ Sentiment: Buy Disclosure: Held
12 Upvote

3 Great analysis

Reply

Top Stories

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Bitcoin investors need to know the risks

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets